Data as of Jul 25, 2026 · Based on 2,718,867 AI responses across 9,511 prompts · See how Parse measures this
Agiosagios.com · Low evidenceAgios is a biopharmaceutical company pioneering therapies in cellular metabolism for rare diseases. The company focuses on developing disease-modifying treatments for hemolytic and acquired anemias, prioritizing patient collaboration to address unmet needs.
Parse Score